Tschernia, Nicholas P. http://orcid.org/0000-0002-2389-9974
Gulley, James L. http://orcid.org/0000-0002-6569-2912
Funding for this research was provided by:
National Cancer Institute (ZIA BC 010945)
Article History
Accepted: 21 February 2022
First Online: 30 March 2022
Declarations
:
: Intramural Research Program of the Center for Cancer Research, NCI, NIH (ZIA BC 010945).
: N.T. and J.G. are employees of the National Cancer Institute, National Institutes of Health. J.G. is a senior investigator on clinical studies using bintrafusp alfa. The National Cancer Institute has a cooperative research and development agreement with EMD Serono. N.T. and J.G. have no other conflicts of interest to declare that might be relevant to the contents of this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: N.T. and J.G. conceived of the review scope, drafted the manuscript, and reviewed and approved the manuscript.